Epigral Ltd. (EPIGRAL) - Total Liabilities

Latest as of June 2026: Rs-22.21 Billion INR ≈ $-240.24 Million USD

Based on the latest financial reports, Epigral Ltd. (EPIGRAL) has total liabilities worth Rs-22.21 Billion INR (≈ $-240.24 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Epigral Ltd. asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Epigral Ltd. - Total Liabilities Trend (2015–2026)

This chart illustrates how Epigral Ltd.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Epigral Ltd. balance sheet assets.

Epigral Ltd. Competitors by Total Liabilities

The table below lists competitors of Epigral Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Zhenhai PetroChem Engineering SHG:603637	China	CN¥265.87 Million
GS P&L CO LTD KO:499790	Korea	₩1.17 Trillion
Anhui Xinli Finance Co Ltd SHG:600318	China	CN¥2.37 Billion
Veradigm Inc. NASDAQ:MDRX	USA	$513.64 Million
Velesto Energy Bhd KLSE:5243	Malaysia	RM350.67 Million
4D Molecular Therapeutics Inc NASDAQ:FDMT	USA	$61.05 Million
Invesco Quality Municipal Income Closed Fund NYSE:IQI	USA	$297.67 Million
Anglo American PLC LSE:AAL	UK	GBX34.43 Billion

Liability Composition Analysis (2015–2026)

This chart breaks down Epigral Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Epigral Ltd. (EPIGRAL) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	N/A	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.00	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	N/A	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Epigral Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Epigral Ltd. (2015–2026)

The table below shows the annual total liabilities of Epigral Ltd. from 2015 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs12.84 Billion ≈ $138.85 Million	+2.88%
2025-03-31	Rs12.48 Billion ≈ $134.96 Million	-18.98%
2024-03-31	Rs15.40 Billion ≈ $166.57 Million	+12.99%
2023-03-31	Rs13.63 Billion ≈ $147.42 Million	-2.47%
2022-03-31	Rs13.98 Billion ≈ $151.16 Million	+82.81%
2021-03-31	Rs7.65 Billion ≈ $82.69 Million	+10.81%
2020-03-31	Rs6.90 Billion ≈ $74.62 Million	+25.12%
2019-03-31	Rs5.51 Billion ≈ $59.64 Million	+259.21%
2018-03-31	Rs1.54 Billion ≈ $16.60 Million	-7.43%
2017-03-31	Rs1.66 Billion ≈ $17.93 Million	-32.24%
2016-03-31	Rs2.45 Billion ≈ $26.47 Million	-22.05%
2015-03-31	Rs3.14 Billion ≈ $33.96 Million	--

About Epigral Ltd.

NSE:EPIGRAL India Chemicals

Market Cap

$515.69 Million

Rs47.68 Billion INR

Market Cap Rank

#12201 Global

#617 in India

Share Price

Rs1105.30

Change (1 day)

+0.35%

52-Week Range

Rs810.45 - Rs1753.70

All Time High

Rs2344.35